A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update.
European Journal of Cancer.
Times cited: 271
Pazopanib in locally advanced or metastatic renal cell carcinoma: Results of a randomized phase III trial.
Journal of Clinical Oncology.
Times cited: 1739
Clinico-pathological characteristics of prostate cancer in Korean men and nomograms for the prediction of the pathological stage of the clinically localized prostate cancer: A multi-institutional update.
Korean Journal of Urology.
Times cited: 10
Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy.
Times cited: 54